Table 3 Agreement (kappa statistic and standard error) between self-reported morbidity in TILDA and Rx-Risk-V algorithm (≥ 65 years)
TILDA | Rx-Risk-V Pharmacy claims | Kappa (κ) | Standard Error | ||||
|---|---|---|---|---|---|---|---|
Self-reported morbidity | N | % | Medication-based Morbidity (ATC) | N | % | ||
Diabetes or high blood sugar | 222 | (12.13) | Diabetes (A10AB01-A10BG03, A10BH, A10BX) | 191 | (10.44) | 0.81 | 0.02 |
Glaucoma | 82 | (4.48) | Glaucoma (S01EA01-S01EB03, S01EC03-S01EX) | 104 | (5.68) | 0.69 | 0.02 |
Osteoporosis | 253 | (13.83) | Osteoporosis/Paget’s disease (M05BA01-M05BB09, M05BX03, G03XC01, A12AX92) | 306 | (16.72) | 0.61 | 0.02 |
Parkinson | 17 | (0.93) | Parkinson’s disease (N04AA01-N04BX02) | 40 | (2.19) | 0.56 | 0.02 |
Angina | 213 | (11.64) | Angina (C01DA02-C01DA14, C01DX16, C01EB17-C01EB18) | 194 | (10.60) | 0.51 | 0.02 |
High Cholesterol | 733 | (40.05) | Hyperlipidaemia (C10AA01-C10BX17) | 1002 | (54.75) | 0.44 | 0.02 |
Manic depression | 5 | (0.27) | Bipolar disorder (N05AN01) | 6 | (0.33) | 0.36 | 0.02 |
High blood pressure or Hypertension | 964 | (52.68) | Hypertension (C03AA01-C03BA11, C03DA01-C03EA01, C09BA02-C09BA09, C09DA01-C09DA09, C02AB01-C02AC05, C02DB02-C02KX01) | 591 | (32.30) | 0.36 | 0.02 |
Pain (taking pain medication) | 464 | (25.36) | Pain (Opioids) (N02AA01-N02AX02) Pain (Inflammation) (M01AB01, M01AH06) | 523 | (28.58) | 0.35 | 0.02 |
Pain | 726 | (39.67) | Pain (Opioids) (N02AA01-N02AX02) Pain (Inflammation) (M01AB01, M01AH06) | 523 | (28.58) | 0.27 | 0.02 |
Abnormal Heart Rhythm | 221 | (12.08) | Arrhythmia (C01AA05, C01BA01-C01BD01, C01BD07) | 103 | (5.63) | 0.26 | 0.02 |
Depression | 78 | (4.26) | Depression (N06AA01-N06AG02, N06AX) | 359 | (19.62) | 0.21 | 0.02 |
Dementia | 5 | (0.27) | Dementia (N06DA02, N06DA01) | 24 | (1.31) | 0.20 | 0.02 |
Chronic lung disease such as chronic bronchitis or emphysema | 97 | (5.30) | Chronic airways disease (R03AC02-R03DC03) | 457 | (24.97) | 0.19 | 0.02 |
Cancer or a malignant tumour | 177 | (9.67) | Malignancies (L01AA01-L01XX31) | 62 | (3.39) | 0.19 | 0.02 |
Emotional nervous or psychiatric problem, such as depression or anxiety | 115 | (6.28) | Anxiety (N05BA01- N05BA12) | 327 | (17.87) | 0.15 | 0.02 |
Congestive heart failure | 31 | (1.69) | Chronic heart failure (C03CA01-C03CC01, C09AA01-C09AA10, C09CA01, C09CA03, C09CA06-C09CA07) | 269 | (14.70) | 0.13 | 0.01 |
Cirrhosis or serious liver damage | 10 | (0.55) | Liver disease (A05AA01-A05BA08, J05AF05, J05AF07, J05AF11) | 6 | (0.33) | 0.12 | 0.02 |
Heart attack (including myocardial infarction or coronary thrombosis) | 171 | (9.34) | Anti-platelet therapy (B01AC04-B01AC30) | 952 | (52.02) | 0.11 | 0.01 |
Anxiety | 66 | (3.61) | Anxiety (N05BA01-N05BA12) | 327 | (17.87) | 0.11 | 0.02 |
Stomach ulcers | 127 | (6.94) | GORD & Peptic ulcer (A02BA, A02BC) | 947 | (51.75) | 0.10 | 0.01 |
Alcohol or substance abuse | 28 | (1.53) | Alcohol dependence (N07BB01, N07BB04) | 1 | (0.05) | 0.07 | 0.01 |
Any other heart trouble | 101 | (5.52) | Ischaemic heart disease/hypertension (C07AA01-C07FB07, C08CA01-C08DB01) | 884 | (48.31) | 0.06 | 0.01 |
Stroke (cerebral vascular disease) | 61 | (3.33) | Anti-platelet therapy (B01AC04-B01AC30) | 952 | (52.02) | 0.04 | 0.01 |
Mini-stroke or TIA | 131 | (7.16) | Anti-platelet, Anti-coagulation therapya (B01AC04-B01AC30, B01AA03-B01AB06, B01AB10) | 1104 | (60.32) | 0.02 | 0.01 |
Incontinence | 313 | (17.10) | Neurogenic Bladder & Urinary Incontinence (V07AN) | 17 | (0.93) | 0.02 | 0.01 |
Psychosis | 1 | (0.05) | Psychotic illness (N05AA01- N05AX17) | 150 | (8.20) | 0.01 | 0.00 |